- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06531174
Exploring Individual Nutrition Care Elements and Nutritional Evaluation Methods Within Dietetic Practice in Cancer Care
The purpose of the study is to explore and deepen the understanding of the dietitian's role and work related to individually tailored nutritional treatment in cancer care. The research questions focus on behavior change strategies, goal setting, the possibility of using calf circumference to assess changes in muscle mass, and mapping energy and protein intake, nutritional symptoms, and food-related quality of life during nutritional treatment for cancer patients.
In the first part of the project, audio recordings of conversations between dietitians and patients with cancer will be conducted to investigate the dietitian's work with behavior change strategies and goal setting. Data analysis will be performed using two different methods: content analysis and thematic analysis. The research subjects include both dietitians and cancer patients who engage in conversations.
The second part of the project will include 100 patients with cancer at risk for or with malnutrition. Data collection will involve measurements of weight, height, calf circumference, muscle mass, energy and protein intake, nutritional symptoms, and food-related quality of life.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Evelina Liljeberg, PhD
- Phone Number: +46184715016
- Email: evelina.liljeberg@ikv.uu.se
Study Contact Backup
- Name: Karin Jontell, MSc
- Email: karin.jontell@ikv.uu.se
Study Locations
-
-
-
Uppsala, Sweden
- Recruiting
- Uppsala University
-
Contact:
- Evelina Liljeberg, PhD
- Email: evelina.liljeberg@ikv.uu.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
In the first part of the project (non-probability sampling method), research participants are registrered dietitians in Sweden and patients with cancer who have malnutrition or are at risk of malnutrition. The participants are recruited systematically through a strategic or purposive selection within the hospital setting.
For the second part of the project (probability sampling method), research participants are patients aged ≥18 years with a diagnosed cancer who are receiving or scheduled to receive treatment, including surgical, oncological, or a combination of these, at Uppsala University Hospital in Uppsala. The patients should have been referred to a dietitian but have not yet had their initial contact with the dietitian at the time of inclusion.
Description
Inclusion Criteria:
Inclusion criteria for the first part of the project involve encountering dietitians treating patients with cancer who have malnutrition or are at risk of malnutrition. For these patients, the inclusion criteria are as follows:
- aged ≥18 years with a diagnosed cancer
- ongoing nutrition therapy by a dietitian
- malnutrition or risk of malnutrition according to the hospitals criteria where at least one of the following criteria must be met: low BMI, involuntary weight loss, and/or eating difficulties. Patients can also be included if they are referred to a dietitian based on treatment guidelines due to a high risk of malnutrition associated with the cancer diagnosis or its medical therapy.
For the second part of the project, the inclusion criteria are:
- aged ≥18 years with a diagnosed cancer
- undergoing or planned treatment, including surgical, oncological, or a combination of these
- have been referred to a dietitian but have not yet had their initial contact with the dietitian, and
- malnutrition or risk of malnutrition according to the hospital's criteria, where at least one of the following criteria must be met: low BMI, involuntary weight loss, and/or eating difficulties. Patients can also be included if they are referred to a dietitian based on treatment guidelines due to a high risk of malnutrition associated with the cancer diagnosis or its medical therapy.
Exclusion Criteria:
For the first part of the project, the exclusion criteria regarding patients are:
- known dementia or impaired cognitive function, and
- not proficient in spoken and written Swedish.
For the second part of the project, the exclusion criteria are:
- known dementia or impaired cognitive function,
- ongoing nutrition therapy by a dietitian at inclusion, and
- not proficient in spoken and written Swedish.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calf Circumference
Time Frame: Baseline, 1 month and 3 months
|
Measured on right and left calf
|
Baseline, 1 month and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fat Free Mass and Fat Mass
Time Frame: Baseline, 1 month and 3 months
|
Measured with bioimpedance analysis
|
Baseline, 1 month and 3 months
|
|
Food-Related Quality of Life
Time Frame: Baseline, 1 month and 3 months
|
Measured with the questionnaire Satisfaction with Food-Related Life.
This instrument contains seven statements where the participant responds on a seven-point scale from 'Strongly disagree' to 'Strongly agree'.
A higher rating indicates a worse outcome.
|
Baseline, 1 month and 3 months
|
|
Energy and Protein Intake
Time Frame: Baseline, 1 month and 3 months
|
Measure with a repeated 24 h recall interview
|
Baseline, 1 month and 3 months
|
|
Nutrition Impact Symptoms
Time Frame: Baseline, 1 month and 3 months
|
Measured with the Eating Symptoms Questionnaire (13 symtoms to be rated on a five-level scale from no trouble at all to severe) and the Disease-Related Appetite Questionnaire (11 questions about appetite, hunger and other symtoms).
A higher number of symtoms indicates a worse outcome.
|
Baseline, 1 month and 3 months
|
|
Quality of Life
Time Frame: Baseline, 1 month and 3 months
|
Measured with the instrument EORTC QLQ-C30.
Includes 28 symptoms or issues, each rated on a four-level scale from 1= 'not at all' to 4 = 'very much.
A higher score indicates a worse outcome.
The lowest aggregated score of the instrument is 28 and the highest is 112.
The instrument also contains two questions where one is to rate their overall health and quality of life on a seven-level scale from 1= 'Very poor" to 7= 'Excellent'.
|
Baseline, 1 month and 3 months
|
|
Muscle Function and Strength
Time Frame: Baseline, 1 month and 3 months
|
Measured with 30s chair stand test and hand dynamometer
|
Baseline, 1 month and 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Categories and frequencies of Behaviour Change Strategies
Time Frame: Baseline
|
For part 1 of the project, data is collected by conversation recordings.
The behaviour change taxonomy (v1) by Miche et al (2013) will be used to categorize and count the strategies.
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Evelina Liljeberg, PhD, Uppsala University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 240901
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States